In-Host Evolution of Daptomycin Resistance and Heteroresistance in Methicillin-Resistant Staphylococcus aureus Strains From Three Endocarditis Patients

The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification

(2019) Hervé Nicoloff et al.   Nature Microbiology

Characterization of genetic changes associated with daptomycin nonsusceptibility in Staphylococcus aureus

(2018) Zhuo Ma et al.   PLoS One

Daptomycin

(2017) Mohsen Heidary et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Fitness Cost of Daptomycin-Resistant Staphylococcus aureus Obtained from in Vitro Daptomycin Selection Pressure

(2017) Shuguang Li et al.   Frontiers in Microbiology

Vancomycin susceptibility in methicillin-resistant Staphylococcus aureus is mediated by YycHI activation of the WalRK essential two-component regulatory system

(2016) David R. Cameron et al.   Scientific Reports

Stepwise Decrease in Daptomycin Susceptibility in Clinical Staphylococcus aureus Isolates Associated with an Initial Mutation inrpoBand a Compensatory Inactivation of theclpXGene

(2015) Kristoffer T. Bæk et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antimicrobial Heteroresistance: an Emerging Field in Need of Clarity

(2015) Omar M. El-Halfawy et al.   CLINICAL MICROBIOLOGY REVIEWS

Prokka: rapid prokaryotic genome annotation

(2014) T. Seemann   BIOINFORMATICS

Tigecycline resistance in Acinetobacter baumannii mediated by frameshift mutation in plsC, encoding 1-acyl-sn-glycerol-3-phosphate acyltransferase

(2014) X. Li et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

High-Dose Daptomycin Therapy for Staphylococcal Endocarditis and When to Apply It

(2014) Jordan R. Smith et al.   Current Infectious Disease Reports

dltA overexpression: A strain-independent keystone of daptomycin resistance in methicillin-resistant Staphylococcus aureus

(2013) Viviana Cafiso et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Mechanisms and fitness costs of tigecycline resistance in Escherichia coli

(2013) M. Linkevicius et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

National Surveillance of Methicillin-Resistant Staphylococcus aureus in China Highlights a Still-Evolving Epidemiology with 15 Novel Emerging Multilocus Sequence Types

(2013) Meng Xiao et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Asia

(2013) Yu-Yu Chuang et al.   LANCET INFECTIOUS DISEASES

Mechanisms of daptomycin resistance inStaphylococcus aureus: role of the cell membrane and cell wall

(2012) Arnold S. Bayer et al.   Annals of the New York Academy of Sciences

VraSR Two-Component Regulatory System Contributes tomprF-Mediated Decreased Susceptibility to Daptomycin inIn Vivo-Selected Clinical Strains of Methicillin-Resistant Staphylococcus aureus

(2011) Shrenik Mehta et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

An RpoB Mutation Confers Dual Heteroresistance to Daptomycin and Vancomycin in Staphylococcus aureus

(2010) L. Cui et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Limitations of antibiotic options for invasive infections caused by methicillin-resistant Staphylococcus aureus: is combination therapy the answer?

(2009) H. M. Nguyen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY